Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My ‐LIFE European Delphi survey

ConclusionsThis survey identifies two relevant outcome measures: one objective (use of acute migraine treatment medications) and one subjective (positive patient perception) that guide the clinician decision to continue preventive treatment in migraine patients.

Source: European Journal of Pain - June 26, 2021 Category: Anesthesiology Authors: P. Pozo ‐Rosich, R. Gil‐Gouveia, A. Donnet, A. C. Poole, A. Gendolla, S. Afridi, R. Sanchez‐De la Rosa, G. M. Terwindt, C. Tassorelli Tags: ORIGINAL ARTICLE Source Type: research